Stefanie Liedtke
Overview
Explore the profile of Stefanie Liedtke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
910
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Becker F, Ouzin M, Liedtke S, Raba K, Kogler G
Stem Cells
. 2023 Nov;
42(2):158-171.
PMID: 37962865
Hematopoietic stem cells (HSC) from cord blood can be applied as an alternative to bone marrow in transplantation to treat hematological diseases. Umbilical cord blood (UCB) consists of cycling and...
2.
Liedtke S, Tobben S, Gressmann H, Meyer A, Verde P, Gluckman E, et al.
Stem Cells Transl Med
. 2023 Nov;
13(1):30-42.
PMID: 37936262
The José Carreras Cord Blood Bank (CBB) located in Düsseldorf as of today stores 21 215 active cryopreserved cord blood units (CBUs) applicable as a source for hematopoietic stem cell...
3.
Liedtke S, Gravemeyer S, Kamga Wambo G
J Health Monit
. 2023 Jun;
2(Suppl 2):13-16.
PMID: 37377533
The Preventive Health Care Act Germany adopted in July 2015 defines that the institutions involved in the National Prevention Conference have to publish a prevention report on a four year...
4.
Trepanier P, Fournier D, Simard C, Fontaine M, Stroncek D, Takanashi M, et al.
Transfusion
. 2022 Jun;
62(8):1595-1601.
PMID: 35770742
Background: The IL-3-pSTAT5 assay, a new, rapid, and standardized flow-cytometry-based assay may compensate for several limitations of the colony-forming unit (CFU) assay typically used for stem cell potency assessments of...
5.
Liedtke S, Gravemeyer S, Kamga Wambo G
J Health Monit
. 2022 May;
3(Suppl 2):7.
PMID: 35586468
No abstract available.
6.
Liedtke S, Korschgen L, Korn J, Duppers A, Kogler G
Vox Sang
. 2020 Jul;
116(1):123-135.
PMID: 32687634
Background: Based on a synergistic consortium, the cord blood (CB) bank Düsseldorf was responsible for the selection of HLA-homozygous (HLA-h) donors, contacting/re-consenting the mothers, Good Manufacturing Practice (GMP)-grade CD34 enrichment,...
7.
Fournier D, Lewin A, Simard C, Trepanier P, Neron S, Ballerini L, et al.
Cytotherapy
. 2019 Dec;
22(1):44-51.
PMID: 31883947
Background Aims: In 2016, specifications for both pre-cryopreserved and post-thawed cord blood were defined in the sixth edition of NetCord Foundation for the Accreditation of Cellular Therapy (FACT) Standards for...
8.
Schwandt S, Liedtke S, Kogler G
Cytotherapy
. 2017 Jun;
19(8):962-977.
PMID: 28645734
Background: Hematopoietic stem cell (HSC) viability and potency is crucial for qualified cord blood (CB) transplants. This study analyzes time and temperature condition before cryopreservation for the viability of CD34/CD45...
9.
Sacchetti B, Funari A, Remoli C, Giannicola G, Kogler G, Liedtke S, et al.
Stem Cell Reports
. 2016 Jun;
6(6):897-913.
PMID: 27304917
A widely shared view reads that mesenchymal stem/stromal cells ("MSCs") are ubiquitous in human connective tissues, can be defined by a common in vitro phenotype, share a skeletogenic potential as...
10.
Liedtke S, Sacchetti B, Laitinen A, Donsante S, Klockers R, Laitinen S, et al.
J Tissue Eng Regen Med
. 2016 May;
11(10):2725-2736.
PMID: 27214005
Effects of oxygen tension on the generation, expansion, proliferation and differentiation of stromal cell types is widely described in the literature. However, data on the internal heterogeneity of applied cell...